These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2653118)

  • 41. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
    Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
    J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*.
    De Backer D; Aldecoa C; Njimi H; Vincent JL
    Crit Care Med; 2012 Mar; 40(3):725-30. PubMed ID: 22036860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vasopressors for hypotensive shock.
    Lampard JG; Lang E
    Ann Emerg Med; 2013 Mar; 61(3):351-2. PubMed ID: 23026787
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock.
    Hannemann L; Reinhart K; Grenzer O; Meier-Hellmann A; Bredle DL
    Crit Care Med; 1995 Dec; 23(12):1962-70. PubMed ID: 7497718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients.
    Martin C; Viviand X; Arnaud S; Vialet R; Rougnon T
    Crit Care Med; 1999 Sep; 27(9):1708-13. PubMed ID: 10507587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemodynamic effects of isoproterenol and noradrenalin in experimental shock.
    Dedichen H; Schenk WG
    Acta Chir Scand; 1973; 139(3):213-8. PubMed ID: 4698482
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study.
    Levy B; Bollaert PE; Charpentier C; Nace L; Audibert G; Bauer P; Nabet P; Larcan A
    Intensive Care Med; 1997 Mar; 23(3):282-7. PubMed ID: 9083230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of survivors' cardiorespiratory values as therapeutic goals in septic shock.
    Edwards JD; Brown GC; Nightingale P; Slater RM; Faragher EB
    Crit Care Med; 1989 Nov; 17(11):1098-103. PubMed ID: 2791588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
    Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
    Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Editorial: Bacteraemic shock.
    Lancet; 1974 Feb; 1(7852):296-7. PubMed ID: 4130477
    [No Abstract]   [Full Text] [Related]  

  • 51. [The use of sympathomimetics and sympatholytics in shock].
    Torsti P
    Duodecim; 1971; 87(4):297-304. PubMed ID: 5547048
    [No Abstract]   [Full Text] [Related]  

  • 52. Terlipressin for norepinephrine-resistant septic shock.
    O'Brien A; Clapp L; Singer M
    Lancet; 2002 Apr; 359(9313):1209-10. PubMed ID: 11955542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-dose vasopressin is not superior to norepinephrine in septic shock.
    Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
    Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of clinical effect of dopamine and norepinephrine in the treatment of septic shock.
    Du Y; Wang L; Shi H; Gao M
    Pak J Pharm Sci; 2015 Jul; 28(4 Suppl):1461-4. PubMed ID: 26431658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of norepinephrine on right ventricular function in septic shock patients.
    Martin C; Perrin G; Saux P; Papazian L; Gouin F
    Intensive Care Med; 1994 Jul; 20(6):444-7. PubMed ID: 7798451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Use of norepinephrine in the treatment of septic shock].
    Martin C; Eon B; Saux P; Albanese J; Aknin P; Gouin F
    Ann Fr Anesth Reanim; 1989; 8(1):19-25. PubMed ID: 2712404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Norepinephrine, dibenzyline and endotoxin shock.
    Sukhnandan R; Wilson RF; Thal AP
    J Okla State Med Assoc; 1966 Aug; 59(8):446-50. PubMed ID: 5944534
    [No Abstract]   [Full Text] [Related]  

  • 58. Hemodynamic studies and results of therapy in 50 patients with bacteremic shock.
    Winslow EJ; Loeb HS; Rahimtoola SH; Kamath S; Gunnar RM
    Am J Med; 1973 Apr; 54(4):421-32. PubMed ID: 4696004
    [No Abstract]   [Full Text] [Related]  

  • 59. The renal and neurohumoral effects of the addition of low-dose dopamine in septic critically ill patients.
    Girbes AR; Patten MT; McCloskey BV; Groeneveld AB; Hoogenberg K
    Intensive Care Med; 2000 Nov; 26(11):1685-9. PubMed ID: 11193277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines.
    Lherm T; Troché G; Rossignol M; Bordes P; Zazzo JF
    Intensive Care Med; 1996 Mar; 22(3):213-9. PubMed ID: 8727434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.